SEC Form 4 · accession 0000899243-18-020264
Crinetics Pharmaceuticals, Inc. · CRNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Seth Krasner
Officer — Chief Medical Officer
Period of report
Jul 20, 2018
Accepted (ET)
Jul 20, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001658247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 20, 2018 | P | 2,000 | $17.00 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney